2
Announcements
Trials
Browse
Landscape
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Sarcoma
2
Conditions
Carcinoma, Basal Cell
4
Pilonidal Sinus
2
Chalazion
2
Bone Neoplasms
2
Recurrence
1
Pain
1
Keratosis, Actinic
1
Giant Cell Tumors
1
Giant Cell Tumor of Bone
1
Endometrial Neoplasms
1
Endometrial Hyperplasia
1
Chondrosarcoma
1
Chondroma
1
Carcinoma, Squamous Cell
1
Bone Cysts
1
Interventions
Ibandronic Acid
8
Gemcitabine
8
Doxorubicin
6
Cyclophosphamide
6
Zoledronic Acid
5
Radiation
4
Nivolumab
4
Irinotecan
4
pembrolizumab
3
Vincristine
3
Temozolomide
3
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
Docetaxel
3
Denosumab
3
Cisplatin
3
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
3
regorafenib
2
pegfilgrastim
2
Tranexamic Acid
2
Trabectedin
2
Surveys and Questionnaires
2
Sunitinib
2
Standard of Care
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Radiosurgery
2
Quality of Life
2
Proton Therapy
2
Observation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Bone Neoplasms
×
Curettage
×
Clear all
NCT02996734
2016-12-22
GCTLIMBS
Istituto Ortopedico Rizzoli
Completed
412 enrolled
NCT02996747
2016-12-22
CONDRO1
Istituto Ortopedico Rizzoli
Completed
102 enrolled